Unique vulnerability of RAC1-mutant melanoma to combined inhibition of CDK9 and immune checkpoints-Reference-Cited by-同舟云学术

Unique vulnerability of RAC1-mutant melanoma to combined inhibition of CDK9 and immune checkpoints

Published:2024-01-19 Issue:10 Volume:43 Page:729-743
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Cannon Alexa C.,Budagyan Konstantin,Uribe-Alvarez Cristina,Kurimchak Alison M.^ORCID,Araiza-Olivera Daniela,Cai Kathy Q.,Peri Suraj,Zhou Yan^ORCID,Duncan James S.,Chernoff Jonathan^ORCID

Funder

Melanoma Research Foundation

U.S. Department of Health & Human Services | NIH | National Cancer Institute

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41388-024-02947-z.pdf

Reference49 articles.

1. Hodis E, Watson IR, Kryukov GV, Arold ST, Imielinski M, Theurillat JP, et al. A landscape of driver mutations in melanoma. Cell 2012;150:251–63.

2. Krauthammer M, Kong Y, Ha BH, Evans P, Bacchiocchi A, McCusker JP, et al. Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma. Nat Genet. 2012;44:1006–14.

3. Davis MJ, Ha BH, Holman EC, Halaban R, Schlessinger J, Boggon TJ. RAC1P29S is a spontaneously activating cancer-associated GTPase. Proc Natl Acad Sci USA. 2013;110:912–7.

4. Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2:401–4.

5. Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6:pl1.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Resolving the current controversy of use and reuse of housekeeping proteins in ageing research: Focus on saving people’s tax dollars;Ageing Research Reviews;2024-09